Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.950
+0.030 (1.56%)
At close: Aug 17, 2026, 4:00 PM EDT
1.980
+0.030 (1.54%)
After-hours: Aug 17, 2026, 6:46 PM EDT
Century Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Century Therapeutics stock has a consensus rating of "Buy" and an average price target of $4.75. The average 1-year stock price forecast is 143.59% higher than the current stock price, while the lowest is $2.00 (+2.56%) and the highest is $8.00 (+310.26%).
Price Target: $4.75 (+143.59%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Century Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 1 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 3 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $8 | Buy | Maintains | $8 | +310.26% | Aug 17, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 | Buy | Reiterates | $5 | +156.41% | Aug 13, 2026 |
Unknown Analyst Clear Street No rating | Clear Street | Buy Maintains $6.6 | Buy | Maintains | $6.6 | +238.46% | Aug 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $4 | Buy | Reiterates | $4 | +105.13% | Jun 9, 2026 |
Financial Forecast
Revenue This Year
n/a
from 109.16M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-0.48
from -0.03
EPS Next Year
-0.45
from -0.48
EPS and Forward PE are based on non-GAAP adjusted numbers.